Chemed Ev To Sales vs Roic Analysis
CHE Stock | USD 547.55 0.29 0.05% |
Chemed Corp financial indicator trend analysis is way more than just evaluating Chemed Corp prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Chemed Corp is a good investment. Please check the relationship between Chemed Corp Ev To Sales and its Roic accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemed Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. For information on how to trade Chemed Stock refer to our How to Trade Chemed Stock guide.
Ev To Sales vs Roic
Ev To Sales vs Roic Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Chemed Corp Ev To Sales account and Roic. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Chemed Corp's Ev To Sales and Roic is 0.85. Overlapping area represents the amount of variation of Ev To Sales that can explain the historical movement of Roic in the same time period over historical financial statements of Chemed Corp, assuming nothing else is changed. The correlation between historical values of Chemed Corp's Ev To Sales and Roic is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ev To Sales of Chemed Corp are associated (or correlated) with its Roic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Roic has no effect on the direction of Ev To Sales i.e., Chemed Corp's Ev To Sales and Roic go up and down completely randomly.
Correlation Coefficient | 0.85 |
Relationship Direction | Positive |
Relationship Strength | Strong |
Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Roic
Return on Invested Capital, a profitability ratio that measures the return that an investment generates for those who have provided capital, such as debt holders and equity holders.Most indicators from Chemed Corp's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Chemed Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemed Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. For information on how to trade Chemed Stock refer to our How to Trade Chemed Stock guide.At present, Chemed Corp's Enterprise Value Over EBITDA is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value Multiple is expected to grow to 22.03, whereas Selling General Administrative is forecasted to decline to about 216.4 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 769.8M | 765.1M | 796.6M | 836.4M | Total Revenue | 2.1B | 2.1B | 2.3B | 2.4B |
Chemed Corp fundamental ratios Correlations
Click cells to compare fundamentals
Chemed Corp Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Chemed Corp fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 1.3B | 1.4B | 1.3B | 1.4B | 1.7B | 1.8B | |
Short Long Term Debt Total | 215.9M | 135.4M | 323.5M | 247.0M | 155.1M | 149.1M | |
Other Current Liab | 43.8M | 199.2M | 191.4M | 192.8M | 202.5M | 212.6M | |
Total Current Liabilities | 262.2M | 299.1M | 302.4M | 297.2M | 312.1M | 167.5M | |
Total Stockholder Equity | 726.6M | 901.2M | 623.3M | 798.7M | 1.1B | 1.2B | |
Property Plant And Equipment Net | 287.4M | 311.3M | 318.7M | 335.4M | 330.2M | 346.7M | |
Net Debt | 209.8M | (27.3M) | 290.6M | 172.9M | (108.8M) | (103.4M) | |
Retained Earnings | 1.4B | 1.7B | 2.0B | 2.2B | 2.4B | 2.6B | |
Cash | 6.2M | 162.7M | 32.9M | 74.1M | 264.0M | 277.2M | |
Non Current Assets Total | 1.1B | 1.1B | 1.1B | 1.2B | 1.2B | 1.2B | |
Non Currrent Assets Other | (9.5M) | (11.9M) | (88.2M) | (37.3M) | 161.7M | 169.8M | |
Cash And Short Term Investments | 6.2M | 162.7M | 32.9M | 74.1M | 264.0M | 277.2M | |
Net Receivables | 143.8M | 126.9M | 137.2M | 139.4M | 181.5M | 93.9M | |
Good Will | 577.4M | 578.6M | 578.6M | 581.3M | 585.0M | 339.2M | |
Common Stock Shares Outstanding | 16.5M | 16.4M | 15.9M | 15.1M | 15.2M | 15.9M | |
Liabilities And Stockholders Equity | 1.3B | 1.4B | 1.3B | 1.4B | 1.7B | 1.8B | |
Non Current Liabilities Total | 279.5M | 234.6M | 417.1M | 346.1M | 248.2M | 194.5M | |
Inventory | 7.5M | 7.1M | 10.1M | 10.3M | 12.0M | 16.1M | |
Other Current Assets | 33.2M | 32.8M | 50.1M | 48.8M | 43.4M | 31.9M | |
Other Stockholder Equity | (737.3M) | (861.2M) | (1.4B) | (1.4B) | (1.4B) | (1.3B) | |
Total Liab | 541.7M | 533.7M | 719.5M | 643.3M | 560.2M | 362.0M | |
Property Plant And Equipment Gross | 287.4M | 311.3M | 318.7M | 335.4M | 685.1M | 719.4M | |
Total Current Assets | 190.7M | 329.4M | 230.3M | 272.6M | 500.8M | 525.9M | |
Accumulated Other Comprehensive Income | 2.3M | 2.3M | 2.2M | 2.2M | 2.1M | 2.2M | |
Short Term Debt | 39.3M | 36.2M | 37.9M | 44.0M | 54.3M | 57.1M | |
Intangible Assets | 126.4M | 118.1M | 108.1M | 99.7M | 90.3M | 87.4M | |
Accounts Payable | 51.1M | 54.2M | 73.0M | 41.9M | 48.3M | 39.9M | |
Common Stock Total Equity | 35.3M | 35.8M | 36.3M | 36.5M | 42.0M | 30.2M | |
Common Stock | 35.8M | 36.3M | 36.5M | 36.8M | 37.2M | 31.1M | |
Other Liab | 102.8M | 135.4M | 131.4M | 143.1M | 164.5M | 172.8M | |
Other Assets | 86.5M | 408.8M | 107.0M | 58.0M | 66.7M | 71.8M | |
Treasury Stock | (1.4B) | (1.6B) | (1.8B) | (2.4B) | (2.2B) | (2.1B) | |
Property Plant Equipment | 175.8M | 187.8M | 318.7M | 335.4M | 385.7M | 405.0M | |
Current Deferred Revenue | 128.1M | 166.1M | 152.4M | 38.6M | 6.9M | 6.5M | |
Net Tangible Assets | 22.9M | 204.5M | (63.4M) | 108.8M | 125.1M | 131.4M | |
Retained Earnings Total Equity | 1.2B | 1.4B | 1.7B | 2.0B | 2.3B | 2.4B | |
Long Term Debt Total | 90M | 0.0 | 185M | 92.5M | 83.3M | 91.6M | |
Capital Surpluse | 860.7M | 961.4M | 1.0B | 1.1B | 1.3B | 757.3M | |
Deferred Long Term Liab | 95.0M | 109.1M | 121.8M | 1.7M | 2.0M | 1.9M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Chemed Corp is a strong investment it is important to analyze Chemed Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Chemed Corp's future performance. For an informed investment choice regarding Chemed Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemed Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. For information on how to trade Chemed Stock refer to our How to Trade Chemed Stock guide.You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemed Corp. If investors know Chemed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemed Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.014 | Dividend Share 1.7 | Earnings Share 19.78 | Revenue Per Share 157.577 | Quarterly Revenue Growth 0.074 |
The market value of Chemed Corp is measured differently than its book value, which is the value of Chemed that is recorded on the company's balance sheet. Investors also form their own opinion of Chemed Corp's value that differs from its market value or its book value, called intrinsic value, which is Chemed Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemed Corp's market value can be influenced by many factors that don't directly affect Chemed Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemed Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemed Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemed Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.